Reddit comparison threads on tesamorelin versus CJC-1295 are among the most-read peptide posts, and most of them skip the parts a laboratory buyer actually needs: what each molecule is, how the published research differs, and what to check on the certificate.
What they are
Both are synthetic analogs of growth-hormone-releasing hormone studied in preclinical and clinical research. Tesamorelin is a 44-amino-acid analog with a trans-3-hexenoic acid modification; CJC-1295 is a modified 29-amino-acid fragment, available with or without the drug affinity complex (DAC) that extends its half-life in published studies. The structural difference drives the research-literature difference, which is why the two are not interchangeable in a study design.
What the threads miss
- Which CJC-1295 is meant: with DAC or without. Threads rarely say, and the two have different pharmacokinetic profiles in the literature.
- Published research context: tesamorelin has a clinical-trial literature; much of the CJC-1295 literature is earlier and smaller.
- Certificate details: molecular weight on the mass spec identity check differs between the molecules and between CJC-1295 variants, which is how you confirm which one you received.
Material pages: tesamorelin and CJC-1295. Side-by-side data: /compare. Certificates: /coas. How to read vendor threads: research peptide suppliers: what Reddit gets right and wrong.
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease. The statements made on this website have not been evaluated by the US Food and Drug Administration.
